iifl-logo

Marksans Pharma Ltd Historical Data

193.86
(1.02%)
Dec 12, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Marksans Pharma Ltd Historical Data

14/11/2025calendar-icon
14/12/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-Nov-2025

195

198.07192.23196.9215,90321,28,21,869.515,47,951

13-Nov-2025

197.4

201.3186.75188.3530,32540,97,46,540.548,67,611

14-Nov-2025

191

196.15190.08192.4425,43937,68,32,667.367,26,119

17-Nov-2025

194.42

198.99193.3195.1117,28021,54,47,021.544,23,772

18-Nov-2025

196.57

196.59190.8192.3414,80013,21,85,648.683,33,071

19-Nov-2025

192.2

192.2188.4189.1511,96313,32,50,704.432,85,350

20-Nov-2025

189.89

194188.51193.0712,69317,96,16,909.083,36,375

21-Nov-2025

193.07

193.18189.21191.7313,24313,06,42,136.422,65,690

24-Nov-2025

192.6

193.95187.25188.821,06124,51,62,871.977,54,299

25-Nov-2025

188.4

191.5187.36188.5513,82911,63,54,592.722,58,943

26-Nov-2025

189.5

192.49188.55191.3112,26612,73,04,530.663,16,413

27-Nov-2025

192.06

194.7190190.6112,39711,47,36,885.992,61,990

28-Nov-2025

191.2

193.49187.5187.957,4156,04,83,638.761,63,608

01-Dec-2025

188.1

197.8188.1194.8520,51527,13,00,697.755,42,118

02-Dec-2025

195

195.1190.5192.1512,08110,19,92,574.062,84,791

03-Dec-2025

192

192.65189.03190.210,84610,16,75,621.592,39,009

04-Dec-2025

190.2

190.89187187.811,68110,00,36,713.872,75,502

05-Dec-2025

187.96

188.35182.58183.9713,20612,62,88,526.833,17,573

08-Dec-2025

183.21

186.46179.17184.217,44215,35,55,356.573,94,592

09-Dec-2025

183.28

191.8180.85190.1118,86619,47,35,099.683,99,566

10-Dec-2025

189.61

192.3187.24191.2113,84417,60,51,277.384,73,570

11-Dec-2025

190.06

193.25189.01191.913,12710,47,01,343.742,53,090

12-Dec-2025

192

194.3191.3193.869,90211,35,01,265.972,87,154

Marksans Pharma: Related NEWS

Marksans Pharma’s UK Subsidiary Relonchem Gets MHRA Approval for Moxonidine Tablets

In June, Relonchem also secured approval for oxybutynin hydrochloride oral solution, used in managing symptoms of an overactive bladder.

24 Sep 2025|09:58 AM
Read More
Marksans Pharma Secures EIR from USFDA for Subsidiary’s New York Facility

The inspection by the USFDA had taken place between April 16 and 24. After the visit, the company disclosed one observation under Form 483.

30 Jun 2025|05:57 PM
Read More
OrbiMed to Offload 2.27% Stake in Marksans Pharma via Block Deal

The block deal has been launched at a floor price of ₹249.95 per share, signaling a strategic partial exit by the investor.

11 Jun 2025|12:34 PM
Read More
Marksans Pharma’s Relonchem Gets UK MHRA Approval for Baclofen 10 mg

Relonchem Ltd has secured Marketing Authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for Baclofen 10 mg Tablets

21 Mar 2025|12:02 PM
Read More
Marksans Pharma gets USFDA approval for anti-allergy drug

The US Food and Drug Administration (FDA) approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

22 Nov 2024|02:54 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.